During the past decade, Klinik Hirslanden conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik Hirslanden" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 23 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "Endospan Ltd." with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Hirslanden" #1 collaborator was "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Klinik Hirslanden" are "Lymphoma" (6 trials), "Prostate Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Leukemia" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Klinik Hirslanden" in a lesser frequency.

Most popular intervention types in "Klinik Hirslanden" are "Drug" (20 trials), "Biological" (10 trials), "Radiation" (8 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (4 trials), "radiation therapy" (4 trials), "cyclophosphamide" (3 trials), "docetaxel" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Hirslanden" are 29 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinik Hirslanden". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Klinik Hirslanden, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Hirslanden, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".